Acute effects of troglitazone and nitric oxide on glucose uptake in L929 fibroblast cells

Life Sciences

Volumn 72, Issue 21, 2003, Pages 2321-2327

  Van Dyke, David A ^a   Walters, Lindsey ^a   Frieswyk, Deborah ^a   Kokmeyer, Dan ^a   Louters, Larry L ^a  

^a CALVIN COLLEGE   (United States)

Author keywords

Glucose transport; GLUT 1; L929 fibroblasts; Nitric oxide; Troglitazone

Indexed keywords

CALCIUM ION; DANTROLENE; DEOXYGLUCOSE; GLUCOSE TRANSPORTER 1; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; TROGLITAZONE;

ANIMAL CELL; ARTICLE; CELL STRAIN L 929; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; GLUCOSE TRANSPORT; MOUSE; MUSCLE TISSUE; NONHUMAN; STIMULATION;

EID: 0037432494     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(03)00119-X     Document Type: Article

References (18)

1. Fujiwara T., Yoshioka S., Ushiyama I., Horikoshi H. Characterization of a new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats. Diabetes. 37:1988;1549-1558.
2. Suter S.L., Nolan J.J., Wallace P., Gumbiner B., Olefsky J.M. Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects. Diabetes Care. 15:1992;193-203.
3. Iwamoto Y., Kuzuya T., Matsuda A., Awata T., Kumakura S., Inooka G., Shiraishi I. Effect of new oral antidiabetic agent CS-045 on glucose tolerance and insulin secretion in patients with NIDDM. Diabetes Care. 14:1991;1083-1086.
4. Fujiwara T., Wada M., Fukuda K., Fukami M., Yoshioka S., Yoshioka T., Horikoshi H. Characterization of CS-045, a new oral antidiabetic agent. II. Effects on glycemic control and pancreatic islet structure at a late state of the diabetic syndrome in C57BL/KsJ-db/db mice. Metabolism. 40:1991;1213-1218.
5. Lehmann J.M., Moore L.B., Smith-Oliver T.A., Wilkinson W.O., Wilson T.M., Kliewer S.A. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J. Biol. Chem. 270:1995;12953-12956.
6. DeVos P., Lefebvre A.M., Miller S.G., Guerre-Millo M., Wong K., Saladin R., Hamann L.G., Staels B., Briggs M.R., Auwerx J. Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor γ J. Clin. Invest. 98:1996;1004-1009.
7. Furnsinn C., Neschen S., Noe C., Bisschop M., Roden M., Vogl C., Schneider B., Waldhausl W. Acute non-insulin-like stimulation of rat muscle glucose metabolism by troglitazone in vitro. British Journal of Pharmacology. 122:1997;1367-1374.
8. Lee M.K., Olefsky J.M. Acute Effects of Troglitazone on In Vivo Insulin Action in Normal Rats. Metabolism. 44:1995;1166-1169.
9. Okuno A., Ikeda K., Shiota M., Fujiwara T., Yoshioka S., Sugano T., Horikoshi H. Acute Effect of Troglitazone on Glucose Metabolism in the Absence or Presence of Insulin in Perfused Rat Hindlimb. Metabolism. 46:1997;716-721.
10. Brunmair B., Gras F., Neschen S., Roden M., Wagner L., Waldhäusl W., Furnsinn C. Direct Thiazolidinedione Action on Isolated Rat Skeletal Muscle Fuel Handling is Independent of Peroxisome Proliferator-Activated Receptor-γ-Mediated Changes in Gene Expression. Diabetes. 50:2001;2309-2315.
11. Kobzik K., Reid M.B., Bredt D.S., Stamler J.S. Nitric oxide in skeletal muscle. Nature. 372:1994;546-548.
12. Vander Lugt J.T., Gómez-Márquez J., Caldon J., Louters L.L. Combined effects of troglitazone and muscle contraction on insulin sensitization in Balb-c mouse muscle. Biochimie. 83:2001;445-451.
13. Young M., Radda G., Leighton B. Nitric oxide stimulates glucose transport and metabolism in rat skeletal muscle in vitro. Biochem. J. 322:1997;223-228.
14. Etgen G., Fryburg D., Gibbs M. Nitric Oxide Stimulates Skeletal muscle Glucose Transport Through a Calcium/Contraction- and Phosphatidylinositol-3-Kinase-Independent Pathway. Diabetes. 46:1997;1915-1919.
15. Balon T., Nadler J. Evidence that nitric oxide increases glucose transport in skeletal muscle. J. Appl. Physiol. 82:1997;359-363.
16. Higaki Y., Hirshman M.F., Fujii N., Goodyear L.J. Nitric oxide increases glucose uptake through a mechanism that is distinct from the insulin and contraction pathways in rat skeletal muscle. Diabetes. 50:2001;241-247.
17. Bedard S., Marcotte B., Marette A. Cytokines modulate glucose transport in skeletal muscle by inducing the expression of inducible nitric oxide synthase. Biochem J. 325:1997;487-493.
18. Liong E., Kong S.K., Au K.K., Li J.Y., Xu G.Y., Lee Y.L., Kwok T.T., Choy Y.M., Lee C.Y., Fung K.P. Inhibition of glucose uptake and suppression of glucose transporter 1 mRNA expression in L929 cells by tumour necrosis factor-alpha. Life Sci. 65:1999;PL215-PL220.